OPEN-ANGLE GLAUCOMA
Clinical trials for OPEN-ANGLE GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new OPEN-ANGLE GLAUCOMA trials appear
Sign up with your email to follow new studies for OPEN-ANGLE GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glaucoma device study ends early: what we learned
Disease control TerminatedThis study looked at the long-term safety and effectiveness of the STREAMLINE® Surgical System in people with open-angle glaucoma who had already taken part in an earlier trial. The goal was to see if the device continues to lower eye pressure safely over time. Only 17 people enr…
Matched conditions: OPEN-ANGLE GLAUCOMA
Sponsor: New World Medical, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Glaucoma device vs laser: which lowers eye pressure better?
Disease control TerminatedThis study tested a new device called VISCO™360 that opens blocked drainage channels in the eye to lower pressure, compared to a standard laser treatment (SLT). It included 29 adults with open-angle glaucoma who had already had cataract surgery. The goal was to see which treatmen…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Tiny drops, big hope: new device may ease glaucoma treatment
Symptom relief TerminatedThis study tested a device called Nanodropper that makes smaller eye drops for people with glaucoma or high eye pressure. The goal was to see if smaller drops work just as well as standard drops to lower eye pressure. The study planned to enroll 16 adults who already use a common…
Matched conditions: OPEN-ANGLE GLAUCOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC